These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26796302)

  • 1. Drug Discovery and Development of Antimalarial Agents: Recent Advances.
    Thota S; Yerra R
    Curr Protein Pept Sci; 2016; 17(3):275-9. PubMed ID: 26796302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium kinases as targets for new-generation antimalarials.
    Lucet IS; Tobin A; Drewry D; Wilks AF; Doerig C
    Future Med Chem; 2012 Dec; 4(18):2295-310. PubMed ID: 23234552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinoline hybrids and their antiplasmodial and antimalarial activities.
    Hu YQ; Gao C; Zhang S; Xu L; Xu Z; Feng LS; Wu X; Zhao F
    Eur J Med Chem; 2017 Oct; 139():22-47. PubMed ID: 28800458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: A key review.
    Qin HL; Zhang ZW; Lekkala R; Alsulami H; Rakesh KP
    Eur J Med Chem; 2020 May; 193():112215. PubMed ID: 32179331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in the Development of Chemotherapeutic Agents for Malaria.
    Shrivastava N; Khan SA; Ahmad S; Al-Balushi K; Husain A
    Mini Rev Med Chem; 2021; 21(12):1487-1508. PubMed ID: 33349215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
    Biot C; Dessolin J; Grellier P; Davioud-Charvet E
    Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria chemotherapy: recent advances in drug development.
    Gemma S; Travagli V; Savini L; Novellino E; Campiani G; Butini S
    Recent Pat Antiinfect Drug Discov; 2010 Nov; 5(3):195-225. PubMed ID: 20738242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in the identification and development of anti-malarial agents using virtual screening based approaches.
    Shah P; Tiwari S; Siddiqi MI
    Comb Chem High Throughput Screen; 2015; 18(3):257-68. PubMed ID: 25747437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the active sites of malarial proteases for antimalarial drug discovery: approaches, progress and challenges.
    Roy KK
    Int J Antimicrob Agents; 2017 Sep; 50(3):287-302. PubMed ID: 28668681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches in antimalarial drug discovery and development: a review.
    Aguiar AC; Rocha EM; Souza NB; França TC; Krettli AU
    Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):831-45. PubMed ID: 23147137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloaminopeptidases of the Protozoan Parasite
    Mills B; Isaac RE; Foster R
    J Med Chem; 2021 Feb; 64(4):1763-1785. PubMed ID: 33534577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Progress in the Development of New Antimalarial Drugs with Novel Targets.
    Belete TM
    Drug Des Devel Ther; 2020; 14():3875-3889. PubMed ID: 33061294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum dihydroorotate dehydrogenase: a drug target against malaria.
    Hoelz LV; Calil FA; Nonato MC; Pinheiro LC; Boechat N
    Future Med Chem; 2018 Aug; 10(15):1853-1874. PubMed ID: 30019917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Characterization of ACT-451840: an Antimalarial Drug with a Novel Mechanism of Action.
    Boss C; Aissaoui H; Amaral N; Bauer A; Bazire S; Binkert C; Brun R; Bürki C; Ciana CL; Corminboeuf O; Delahaye S; Dollinger C; Fischli C; Fischli W; Flock A; Frantz MC; Girault M; Grisostomi C; Friedli A; Heidmann B; Hinder C; Jacob G; Le Bihan A; Malrieu S; Mamzed S; Merot A; Meyer S; Peixoto S; Petit N; Siegrist R; Trollux J; Weller T; Wittlin S
    ChemMedChem; 2016 Sep; 11(18):1995-2014. PubMed ID: 27471138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First homology model of Plasmodium falciparum glucose-6-phosphate dehydrogenase: Discovery of selective substrate analog-based inhibitors as novel antimalarial agents.
    Alencar N; Sola I; Linares M; Juárez-Jiménez J; Pont C; Viayna A; Vílchez D; Sampedro C; Abad P; Pérez-Benavente S; Lameira J; Bautista JM; Muñoz-Torrero D; Luque FJ
    Eur J Med Chem; 2018 Feb; 146():108-122. PubMed ID: 29407943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents.
    Meyers MJ; Anderson EJ; McNitt SA; Krenning TM; Singh M; Xu J; Zeng W; Qin L; Xu W; Zhao S; Qin L; Eickhoff CS; Oliva J; Campbell MA; Arnett SD; Prinsen MJ; Griggs DW; Ruminski PG; Goldberg DE; Ding K; Liu X; Tu Z; Tortorella MD; Sverdrup FM; Chen X
    Bioorg Med Chem; 2015 Aug; 23(16):5144-50. PubMed ID: 25797165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Development of Coumarin Derivatives as Potential Antiplasmodial and Antimalarial Agents.
    Hu XL; Gao C; Xu Z; Liu ML; Feng LS; Zhang GD
    Curr Top Med Chem; 2018; 18(2):114-123. PubMed ID: 29243579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian models trained with HTS data for predicting β-haematin inhibition and in vitro antimalarial activity.
    Wicht KJ; Combrinck JM; Smith PJ; Egan TJ
    Bioorg Med Chem; 2015 Aug; 23(16):5210-7. PubMed ID: 25573118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo lead optimization of triazine derivatives identifies potent antimalarials.
    Shandilya A; Hoda N; Khan S; Jameel E; Kumar J; Jayaram B
    J Mol Graph Model; 2017 Jan; 71():96-103. PubMed ID: 27880887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.